BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32645888)

  • 1. The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.
    Ballester-Lopez A; Linares-Pardo I; Koehorst E; Núñez-Manchón J; Pintos-Morell G; Coll-Cantí J; Almendrote M; Lucente G; Arbex A; Magaña JJ; Murillo-Melo NM; Lucia A; Monckton DG; Cumming SA; Ramos-Fransi A; Martínez-Piñeiro A; Nogales-Gadea G
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel heat pulse extension-PCR-based method for detection of large CTG-repeat expansions in myotonic dystrophy type 1.
    Orpana AK; Ho TH; Alagrund K; Ridanpää M; Aittomäki K; Stenman J
    J Mol Diagn; 2013 Jan; 15(1):110-5. PubMed ID: 23159592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.
    Savić D; Rakocvic-Stojanovic V; Keckarevic D; Culjkovic B; Stojkovic O; Mladenovic J; Todorovic S; Apostolski S; Romac S
    Hum Mutat; 2002 Feb; 19(2):131-9. PubMed ID: 11793472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CTG repeat length variation in the
    Ambrose KK; Ishak T; Lian LH; Goh KJ; Wong KT; Ahmad-Annuar A; Thong MK
    BMJ Open; 2017 Mar; 7(3):e010711. PubMed ID: 28363916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.
    Magaña JJ; Cortés-Reynosa P; Escobar-Cedillo R; Gómez R; Leyva-García N; Cisneros B
    Mol Biol Rep; 2011 Feb; 38(2):1341-6. PubMed ID: 20635151
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic Dystrophy Type 1 Clinical, Electrophysiological and Molecular Characterization: Experience at Tertiary Care Centre.
    Khadilkar S; Jagiasi K; Yadav J; Chavan SV; Soni G; Patel B
    J Assoc Physicians India; 2017 Jun; 65(6):32-37. PubMed ID: 28782311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical standards and guidelines for myotonic dystrophy type 1 testing.
    Prior TW;
    Genet Med; 2009 Jul; 11(7):552-5. PubMed ID: 19546810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
    Kalman L; Tarleton J; Hitch M; Hegde M; Hjelm N; Berry-Kravis E; Zhou L; Hilbert JE; Luebbe EA; Moxley RT; Toji L
    J Mol Diagn; 2013 Jul; 15(4):518-25. PubMed ID: 23680132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1.
    Salvatori S; Fanin M; Trevisan CP; Furlan S; Reddy S; Nagy JI; Angelini C
    Neurol Sci; 2005 Oct; 26(4):235-42. PubMed ID: 16193250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
    Johnson NE; Butterfield RJ; Mayne K; Newcomb T; Imburgia C; Dunn D; Duval B; Feldkamp ML; Weiss RB
    Neurology; 2021 Feb; 96(7):e1045-e1053. PubMed ID: 33472919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.
    Pešović J; Perić S; Brkušanin M; Brajušković G; Rakočević-Stojanović V; Savić-Pavićević D
    Neurogenetics; 2017 Dec; 18(4):207-218. PubMed ID: 28942489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.
    Ballester-Lopez A; Koehorst E; Linares-Pardo I; Núñez-Manchón J; Almendrote M; Lucente G; Arbex A; Puente C; Lucia A; Monckton DG; Cumming SA; Pintos-Morell G; Coll-Cantí J; Ramos-Fransi A; Martínez-Piñeiro A; Nogales-Gadea G
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33171734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Tube Dodecaplex PCR Panel of Polymorphic Microsatellite Markers Closely Linked to the
    Lian M; Zhao M; Lee CG; Chong SS
    Clin Chem; 2017 Jun; 63(6):1127-1140. PubMed ID: 28428361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
    Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
    Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype.
    Ballester-Lopez A; Koehorst E; Almendrote M; Martínez-Piñeiro A; Lucente G; Linares-Pardo I; Núñez-Manchón J; Guanyabens N; Cano A; Lucia A; Overend G; Cumming SA; Monckton DG; Casadevall T; Isern I; Sánchez-Ojanguren J; Planas A; Rodríguez-Palmero A; Monlleó-Neila L; Pintos-Morell G; Ramos-Fransi A; Coll-Cantí J; Nogales-Gadea G
    Hum Mutat; 2020 Feb; 41(2):420-431. PubMed ID: 31608518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-radioactive PCR southern method for analysis of CTG repeat in myotonic dystrophy].
    Kozuka N; Tachi N; Ohya K; Uchida E; Kikuchi S; Sengoku Y
    No To Hattatsu; 2003 Sep; 35(5):380-7. PubMed ID: 13677946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.